Physiol. Genomics Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Physiol. Genomics 21: 131-143, 2005; doi:10.1152/physiolgenomics.00259.2004
1094-8341/05 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (5)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sanoudou, D.
Right arrow Articles by Kontrogianni-Konstantopoulos, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sanoudou, D.
Right arrow Articles by Kontrogianni-Konstantopoulos, A.
Received 1 November 2004; accepted in final form 31 January 2005.
Physiological Genomics 21:131-143 (2005)
1094-8341/05 $8.00 © 2005 American Physiological Society

Review

Array lessons from the heart: focus on the genome and transcriptome of cardiomyopathies

Despina Sanoudou1, Elizabeth Vafiadaki1, Demetrios A. Arvanitis1, Evangelia Kranias1,2 and Aikaterini Kontrogianni-Konstantopoulos1,3

1 Molecular Biology Division, Center for Basic Research, Foundation for Biomedical Research of the Academy of Athens, Athens, Greece
2 Department of Pharmacology and Cell Biophysics, College of Medicine, University of Cincinnati, Cincinnati, Ohio
3 Department of Physiology, School of Medicine, University of Maryland Baltimore, Baltimore, Maryland

Our understanding of the cardiovascular system has evolved through the years by extensive studies emphasizing the identification of the molecular and physiological mechanisms involved in its normal function and disease pathogenesis. Major discoveries have been made along the way. However, the majority of this work has focused on specific genes or pathways rather than integrative approaches. In cardiomyopathies alone, over 30 different loci have shown mutations with varying inheritance patterns, yet mostly coding for structural proteins. The emergence of microarrays in the early 1990s paved the way to a new era of cardiovascular research. Microarrays dramatically accelerated the rhythm of discoveries by giving us the ability to simultaneously study thousands of genes in a single experiment. In the field of cardiovascular research, microarrays are having a significant contribution, with the majority of work focusing on end-stage cardiomyopathies that lead to heart failure. Novel molecular mechanisms have been identified, known pathways are seen under new light, disease subgroups begin to emerge, and the effects of various drugs are molecularly dissected. This cross-study data comparison concludes that consistent energy metabolism gene expression changes occur across dilated, hypertrophic, and ischemic cardiomyopathies, while Ca2+ homeostasis changes are prominent in the first two cardiomyopathies, and structural gene expression changes accompany mostly the dilated form. Gene expression changes are further correlated to disease genetics. The future of microarrays in the cardiomyopathy field is discussed with an emphasis on optimum experimental design and on applications in diagnosis, prognosis, and drug discovery.

microarrays; heart failure; calcium homeostasis; structural components; metabolism




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
J.-L. Samuel, M. C. Schaub, M. Zaugg, M. Mamas, W. B. Dunn, and B. Swynghedauw
Genomics in cardiac metabolism
Cardiovasc Res, July 15, 2008; 79(2): 218 - 227.
[Abstract] [Full Text] [PDF]


Home page
PhysiologyHome page
Y. Ikeda, M. Hoshijima, and K. R. Chien
Toward Biologically Targeted Therapy of Calcium Cycling Defects in Heart Failure
Physiology, February 1, 2008; 23(1): 6 - 16.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. Drosatos, D. Sanoudou, K. E. Kypreos, D. Kardassis, and V. I. Zannis
A Dominant Negative Form of the Transcription Factor c-Jun Affects Genes That Have Opposing Effects on Lipid Homeostasis in Mice
J. Biol. Chem., July 6, 2007; 282(27): 19556 - 19564.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
H. Ashrafian and H. Watkins
Reviews of Translational Medicine and Genomics in Cardiovascular Disease: New Disease Taxonomy and Therapeutic Implications: Cardiomyopathies: Therapeutics Based on Molecular Phenotype
J. Am. Coll. Cardiol., March 27, 2007; 49(12): 1251 - 1264.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2005 by the American Physiological Society.